Skip to main content

Preterm Labor: Prediction, Prevention, and Treatment

  • Chapter
  • 56 Accesses

Abstract

Despite extensive efforts by the medical community, preterm delivery remains a major cause of perinatal morbidity and mortality in the United States. The present 8% rate of preterm delivery has been constant for much of this century. Despite the introduction of new pharmacologic agents to arrest preterm labor, protocols to detect patients susceptible to preterm labor, and devices to monitor uterine activity, no decrease in the rate of preterm delivery has occurred.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fedrick J, Anderson AB. Factors associated with spontaneous pre-term birth. Br J Obstet Gynaecol 1976;83:342–350.

    PubMed  CAS  Google Scholar 

  2. Funderburk SJ, Guthrie E, Meldrum D. Suboptimal pregnancy outcome among women with prior abortions and premature births. Am J Obstet Gynecol. 1976; 126: 55–60.

    PubMed  CAS  Google Scholar 

  3. Carr-Hill RA, Hall MH. The repitition of spontaneous preterm labour. Br L Obstet Gynaecol. 1985;92:921–928.

    CAS  Google Scholar 

  4. Keirse MJ, Rush RW, Anderson AB, et al. Risk of pre-term delivery in patients with previous preterm delivery and/or abortion. Br J Obstet Gynaecol. 1978;85:81–85.

    PubMed  CAS  Google Scholar 

  5. Heinonen PK, Saarikoski S, Pystynen P. Reproductive performance of women with uterine anomalies. Acta Ostet Gynecol Scand. 1982;61:157–162.

    CAS  Google Scholar 

  6. Aharoni A, Reiter A, Golan D, et al. Patterns of growth of uterine leiomyomas during pregnancy. A prospective longitudinal study. Br J Obstet Gynaecol. 1988;95: 510–513.

    PubMed  CAS  Google Scholar 

  7. Papiernik E. Proposals for a programmed prevention policy of preterm birth. Clin Obstet Gynecol. 1984;27:614–635.

    PubMed  CAS  Google Scholar 

  8. Hoffman HJ, Bakketeig LS. Risk factors associated with the occurrence of preterm birth. Clin Obstet Gynecol. 1984;27:539–552.

    PubMed  CAS  Google Scholar 

  9. Greenberg RS. The impact of prenatal care in different social groups. Am J Obstet Gynecol. 1983;145:797–801.

    PubMed  CAS  Google Scholar 

  10. Graham GG. Poverty, hunger, malnutrition, prematurity, and infant mortality in the United States. Pediatrics. 1985;75:117–125.

    PubMed  CAS  Google Scholar 

  11. Damstetter C, Shain RN, Gibbs RS. Pregnancy outcome in three racial/ethnic groups in San Antonio. Presented at meeting of Society of Perinatal Obstetricians; February 1989; New Orleans, La. Abstract 369.

    Google Scholar 

  12. Buescher PA, Smith C, Holliday JL, et al. Source of prenatal care and infant birth weight: the case of a North Carolina county. Am J Obstet Gynecol. 1987; 156:204–210.

    PubMed  CAS  Google Scholar 

  13. Meyer MB, Tonascia JA. Maternal smoking, pregnancy complications, and perinatal mortality. Am J Obstet Gynecol. 1977;128:494–502.

    PubMed  CAS  Google Scholar 

  14. Rush D, Stein Z, Süsser M. A randomized controlled trial of prenatal nutritional supplementation in New York City. Pediatrics. 1980;65:683–697.

    PubMed  CAS  Google Scholar 

  15. Murphy JF, Dauncey M, Newcombe R, et al. Employment in pregnancy: prevalence, maternal characteristics, perinatal outcome. Lancet. 1984;2:1163–1166.

    Google Scholar 

  16. Grunebaum A, Minkoff J, Blake D. Pregnancy among obstetricians: a comparison of births before, during, and after residency. Am J Obstet Gynecol. 1987;157:79–83.

    PubMed  CAS  Google Scholar 

  17. Newton RW, Hunt LP. Psychosocial stress in pregnancy and its relation to low birth weight. Br Med J. 1984;288:1191–1194.

    CAS  Google Scholar 

  18. Anderson AB, Turnbull AC. Relationship between length of gestation and cervical dilatation, uterine contractility and other factors during pregnancy. Am J Obstet Gynecol. 1969;105:1207–1214.

    PubMed  CAS  Google Scholar 

  19. Brustman LE, Raptoulis M, Langer O, et al. Changes in the pattern of uterine contractility in relationship to coitus during pregnancies at low and high risk for preterm labor. Obstet Gynecol. 1989;73:166–168.

    PubMed  CAS  Google Scholar 

  20. Daikoku WH, Kaltreider DF, Khouzami VA, et al. Premature rupture of membranes and spontaneous preterm labor: maternal endometritis risks. Obstet Gynecol. 1982; 59:13–20.

    PubMed  CAS  Google Scholar 

  21. Miller JM, Pupkin MJ, Hill GB. Bacterial colonization of amniotic fluid from intact fetal membranes. Am J Obstet Gynecol. 1980;136:796–804.

    PubMed  Google Scholar 

  22. Duff P, Kopelman JN. Subclinical intra-amniotic infection in asymptomatic patients with refractory preterm labor. Obstet Gynecol. 1987;69:756–759.

    PubMed  CAS  Google Scholar 

  23. Bejar R, Curbelo V, Davis C, et al. Premature labor, II: bacterial sources of phospholipase. Obstet Gynecol. 1981;57:479–482.

    PubMed  CAS  Google Scholar 

  24. Minkoff H, Grunebaum AN, Schwarz RH, et al. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol. 1984;150:965–972.

    PubMed  CAS  Google Scholar 

  25. Morales WH, Angel JL, O’Brien WF, et al. A randomized study of antibiotic therapy in idiopathic preterm labor. Obstet Gynecol. 1988;72:829–833.

    PubMed  CAS  Google Scholar 

  26. McGregor JA, French JI, Reller LB, et al. Adjunctive erythromycin treatment for idiopathic preterm labor: results of a randomized, double-blinded, placebo-controlled trial. Am J Obstet Gynecol. 1986;154:98–103.

    PubMed  CAS  Google Scholar 

  27. Creasy RK, Gummer BA, Liggins GC. System for predicting spontaneous preterm birth. Obstet Gynecol. 1980;55:692–695.

    PubMed  CAS  Google Scholar 

  28. Fedrick J. Antenatal identification of women at high risk of spontaneous pre-term birth. Br J Obstet Gynecol. 1976;83:351–354.

    CAS  Google Scholar 

  29. Cousins LM, Hobel CJ, Chang RJ, et al. Serum progesterone and estradiol -17 Beta levels in premature and term labor. Am J Obstet Gynecol. 1977;127:612–615.

    PubMed  CAS  Google Scholar 

  30. Block BS, Liggins, Creasy RK. Preterm delivery is not predicted by serial plasma estradiol or progesterone concentration measurements. Am J Obstet Gynecol. 1984; 150:716–722.

    PubMed  CAS  Google Scholar 

  31. Coulam CB, Wasmoen T, Creasy RK, et al. Major basic protein as a predictor of preterm labor: a preliminary report. Am J Obstet Gynecol. 1987;156:790–796.

    PubMed  CAS  Google Scholar 

  32. Romero R, Mazor M, Oyarzun E, et al. Interleukin-1 and the initiation of preterm labor. Presented at meeting of Society of Perinatal Obstetricians; February 1989; New Orleans, La. Abstract 28.

    Google Scholar 

  33. Branch DW, Scott JR, Kochenour NK et al. Obstetric complication associated with the lupus anticoagulant. N Engl J Med. 1985;313:1322–1326.

    PubMed  CAS  Google Scholar 

  34. Lübbe WF, Liggins GC. Lupus anticoagulant and pregnancy. Am J Obstet Gynecol. 1985;153:322–327.

    PubMed  Google Scholar 

  35. Brock DJ, Barron L, Jelen P, et al. Maternal serum-alpha-fetoprotein measurements as an early indicator of low birth-weight. Lancet. 1977;1:267–268.

    Google Scholar 

  36. Wald N, Cuckle H, Stirrat GM, et al. Maternal serum-alpha-fetoprotein and low birth-weight. Lancet. 1977;1:268–269.

    Google Scholar 

  37. Herron MA, Katz M, Creasy RK. Evaluation of a preterm birth prevention program: preliminary report. Obstet Gynecol. 1982;59:452–456.

    PubMed  CAS  Google Scholar 

  38. Main DM, Gabbe SG, Richardson D, et al. Can preterm deliveries be prevented? Am J Obstet Gynecol. 1985;151:892–898.

    PubMed  CAS  Google Scholar 

  39. Papiernik E, Bouyer J, Yaffe K, et al. Women’s acceptance of a preterm birth prevention program. Am J Obstet Gynecol. 1986;155:939–946.

    PubMed  CAS  Google Scholar 

  40. Meis PJ, Ernest JM, Moore JM, et al. Regional program for prevention of premature birth in northwestern North Carolina. Am J Obstet Gynecol. 1987;157:550–556.

    PubMed  CAS  Google Scholar 

  41. Zlatnik FJ. The applicability of labor inhibition to the problem of prematurity. Am J Obstet Gynecol. 1972;113:704–706.

    PubMed  CAS  Google Scholar 

  42. Papiernik E, Bouyer J, Collin D, et al. Precocious cervical ripening and preterm labor. Obstet Gynecol. 1986;67:238–242.

    PubMed  CAS  Google Scholar 

  43. Neilson JP, Verkuyl AA, Crowther CA, et al. Preterm labor in twin pregnancies: prediction by cervical assessment. Obstet Gynecol. 1988;72:719–723.

    PubMed  CAS  Google Scholar 

  44. Leveno KJ, Cox K, Roark ML. Cervical dilatation and prematurity revisited. Obstet Gynecol. 1986;68:434–435.

    PubMed  CAS  Google Scholar 

  45. Weekes AR, Flynn MJ. Engagement of the fetal head in Primigravidae and its relationship to duration of gestation and time of onset of labour. Br J Obstet Gynecol. 1975;82:7–11.

    CAS  Google Scholar 

  46. Holbrook RH, Falcon J, Herron M, et al. Evaluation of the weekly cervical examination in a preterm birth prevention program. Am J Perinatal. 1987;4:240–244.

    Google Scholar 

  47. Floyd W. Cervical dilatation in the mid-trimester of pregnancy. Obstet Gynecol. 1961;18:380–381.

    PubMed  CAS  Google Scholar 

  48. Baker RC, Goldenberg RL, Davis RO, et al. Warning symptoms and cervical exam changes in women at risk for preterm delivery. Presented at meeting of Society of Perinatal Obstetricians; February 1989; New Orleans, La. Abstract 377.

    Google Scholar 

  49. Suranyi S, Szomolya M. The clinical prediction of premature labour by self-observation of uterine contractility and external tocography. J Perinat Med. 1980;9: 140–141.

    Google Scholar 

  50. Newman RB, Gill PJ, Wittreich P, et al. Maternal perception of prelabor uterine activity. Obstet Gynecol. 1986;68:765–769.

    PubMed  CAS  Google Scholar 

  51. Katz M, Gill PJ, Newman RB. Detection of preterm labor by ambulatory monitoring of uterine activity: a preliminary report. Obstet Gynecol. 1986;68:773–778.

    PubMed  CAS  Google Scholar 

  52. Morrison JC, Martin JN, Martin RW, et al. Prevention of preterm birth by ambulatory assessment of uterine activity: a randomized study. Am J Obstet Gynecol. 1987;156:536–543.

    PubMed  CAS  Google Scholar 

  53. Katz M, Gill PJ, Newman RB. Detection of preterm labor by ambulatory monitoring of uterine activity for the management of oral tocolysis. Am J Obstet Gynecol. 1986; 154:1253–1256.

    PubMed  CAS  Google Scholar 

  54. Aubry RH, Pennington JC. Identification and evaluation of high-risk pregnancy: the perinatal concept. Clin Obstet Gynecol. 1973;16:3–27.

    PubMed  CAS  Google Scholar 

  55. Bell R. The prediction of preterm labour by recording spontaneous antenatal uterine activity. Br J Obstet Gynaecol. 1983;90:884–887.

    PubMed  CAS  Google Scholar 

  56. Katz M, Newman RB, Gill PJ. Assessment of uterine activity in ambulatory patients at high risk of preterm labor and delivery. Am J Obstet Gynecol. 1986;154:44–47.

    PubMed  CAS  Google Scholar 

  57. Main DM, Katz M, Chin G, et al. Intermittent weekly contraction monitoring to predict preterm labor in low-risk women: a blinded study. Obstet Gynecol. 1988; 72:757–760.

    PubMed  CAS  Google Scholar 

  58. Morrison J, Martin R, Gookin K, et al. Comparison of uterine activity versus symptomatology in the detection of preterm labor. Presented at meeting of Society of Perinatal Obstetricians; February 1989; New Orleans, La. Abstract 385.

    Google Scholar 

  59. Newman RB, Richmond GS, Winston YE, et al. Antepartum uterine activity characteristics differentiating true from threatened preterm labor. Presented at meeting of Society of Perinatal Obstetricians; February 1989; New Orleans, La. Abstract 29.

    Google Scholar 

  60. Iams JD, Johnson FF, O’Shaughnessy RW, et al. A prospective random trial of home uterine activity monitoring in pregnancies at increased risk of preterm labor. Am J Obstet Gynecol. 1987;157:638–643.

    PubMed  CAS  Google Scholar 

  61. Korenbrot CC, Aalto LH, Laros RK. The cost effectiveness of stopping preterm labor with beta-adrenergic treatment. N Engl J Med. 1984;310:691–696.

    PubMed  CAS  Google Scholar 

  62. Castle BM, Turnbull AC. The presence of absence of fetal breathing movements predicts the outcome of preterm labour. Lancet. 1983;2:471–472.

    PubMed  CAS  Google Scholar 

  63. Boylan P, O’Donovan P, Owens OJ. Fetal breathing movements and the diagnosis of labor: a prospective analysis of 100 cases. Obstet Gynecol. 1985;66:517–520.

    PubMed  CAS  Google Scholar 

  64. Besinger RE, Comptom AA, Hayashi RH. The presence of absence of fetal breathing movements as a predictor of outcome in preterm labor. Am J Obstet Gynecol. 1987;157:753–757.

    PubMed  CAS  Google Scholar 

  65. Creasy RK, Katz M. Basic research and clinical experience with beta-adrenergic tocolytics in the United States. In: Fuchs F, Stubblefield PG, eds. Preterm Birth: Causes, Prevention and Management. New York, NY: Macmillan; 1984:150–170.

    Google Scholar 

  66. Gonik B, Creasy RK. Preterm labor: its diagnosis and management. Am J Obstet Gynecol. 1986;154:3–8.

    PubMed  CAS  Google Scholar 

  67. Berg G, Andersson RG, Ryden G. Beta-adrenergic receptors in human myometrium during pregnancy: changes in the number of receptors after beta-mimetic treatment. Am J Obstet Gynecol. 1985;151:392–396.

    PubMed  CAS  Google Scholar 

  68. Barden TP, Peter JB, Merkatz IR. Ritodrine hydrochloride: a betamimetic agent for use in preterm labor. Obstet Gynecol. 1980;56:1–6.

    PubMed  CAS  Google Scholar 

  69. Bieniarz J, Motew M, Scommenga A. Uterine and cardiovascular effects of ritodrine in premature labor. Obstet Gynecol. 1972;40:65–73.

    PubMed  CAS  Google Scholar 

  70. Bieniarz J, Ivankovich A, Scommenga A. Cardiac output during ritodrine treatment in premature labor. Am J Obstet Gynecol. 1974;118:910–920.

    PubMed  CAS  Google Scholar 

  71. Fuchs F. Prevention of prematurity. Am J Obstet Gynecol. 1976;126:809–820.

    PubMed  CAS  Google Scholar 

  72. Spellacy WN, Cruz AC, Birk SA, et al. Treatment of premature labor with ritodrine: a randomized controlled study. Obstet Gynecol. 1979;54:220–223.

    PubMed  CAS  Google Scholar 

  73. Larsen JF, Eldon K, Lange AP, et al. Ritrodrine in the treatment of preterm labor: second Danish multicenter study. Obstet Gynecol. 1986;67:607–613.

    PubMed  CAS  Google Scholar 

  74. Merkatz IR, Peter JB, Barden TP. Ritodrine hydrochloride: a betamimetic agent for use in preterm labor. Obstet Gynecol. 1980;56:7–12.

    PubMed  CAS  Google Scholar 

  75. Ingemarsson I. Effect of terbutaline on premature labor. Am J Obstet Gynecol. 1976;125:520–524.

    PubMed  CAS  Google Scholar 

  76. Wallace RL, Caldwell DL, Ansbacher R, et al. Inhibition of premature labor by terbutaline. Am J Obstet Gynecol. 1978;51:387–392.

    CAS  Google Scholar 

  77. Creasy RK, Golbus MS, Laros RK, et al. Oral ritodrine maintenance in the treatment of preterm labor. Am J Obstet Gynecol. 1980;137:212–219.

    PubMed  CAS  Google Scholar 

  78. Brown SM, Tejani NA. Terbutaline sulfate in the prevention of recurrence of premature labor. Obstet Gynecol. 1981;57:22–25.

    PubMed  CAS  Google Scholar 

  79. Stubblefield PG, Heyl PS. Treatment of premature labor with subcutaneous terbutaline. Obstet Gynecol. 1982;59:457–462.

    PubMed  CAS  Google Scholar 

  80. Lam F, Gill P, Smith M, et al. Use of the subcutaneous terbutaline pump for long-term tocolysis. Obstet Gynecol. 1988;72:810–813.

    PubMed  CAS  Google Scholar 

  81. Wagner JM, Morton MJ, Johnson KA, et al. Terbutaline and maternal cardiac function. JAMA. 1981;246:2697–2701.

    PubMed  CAS  Google Scholar 

  82. Benedetti TJ. Maternal complications of parenteral beta-sympathomimetic therapy for preterm labor. Am J Obstet Gynecol. 1983; 145:1–6.

    PubMed  CAS  Google Scholar 

  83. Caritis SN, Lin LS, Toig G, et al. Pharmacodynamics of ritodrine in pregnant women during preterm labor. Am J Obstet Gynecol. 1983;147:752–759.

    PubMed  CAS  Google Scholar 

  84. Katz M, Robertson PA, Creasy RK. Cardiovascular complications associated with terbutaline treatment for preterm labor. Am J Obstet Gynecol. 1981;139:605–608.

    PubMed  CAS  Google Scholar 

  85. Goyert G, Bhatia R, Schubert C, et al. Does intravenous ritodrine therapy cause capillary endothelial damage? Am J Perinatal. 1987;4:331–333.

    CAS  Google Scholar 

  86. Philipsen T, Eriksen PS, Lynggard F. Pulmonary edema following ritodrine-saline infusion in premature labor. Obstet Gynecol. 1981;58:304–308.

    PubMed  CAS  Google Scholar 

  87. Young DC, Toofanian A, Leveno KJ. Potassium and glucose concentrations without treatment during ritodrine tocolysis. Am J Obstet Gynecol. 1983;145:105–106.

    PubMed  CAS  Google Scholar 

  88. Spellacy WN, Cruz AC, Buhi WC, et al. The acute effects of ritrodrine infusion on maternal metabolism: measurements of levels of glucose, insulin, glucagon, triglycerides, cholesterol, placental lactogen, and chorionic gonadotropin. Am J Obstet Gynecol. 1978;131:637–642.

    PubMed  CAS  Google Scholar 

  89. Kauppila A, Tuimala R, Ylikorkala O, et al. Effects of ritodrine and isoxsuprine with the without dexamethasone during late pregnancy. Obstet Gynecol. 1978;51:288–292.

    PubMed  CAS  Google Scholar 

  90. Main DM, Main EK, Strong SE, et al. The effect of oral ritrodrine therapy on glucose tolerance in pregnancy. Am J Obstet Gynecol. 1985;152:1031–1033.

    PubMed  CAS  Google Scholar 

  91. Main EK, Main DM, Gabbe SG. Chronic oral terbutaline tocolytic therapy is associated with maternal glucose intolerance. Am J Obstet Gynecol. 1987; 157: 644–647.

    PubMed  CAS  Google Scholar 

  92. Cruikshank DP, Pitkin RM, Reynolds WA, et al. Effects of magnesium sulfate treatment on perinatal calcium metabolism. Am J Obstet Gynecol. 1979;134:243–249.

    PubMed  CAS  Google Scholar 

  93. Elliott JP. Magnesium sulfate as a tocolytic agent. Am J Obstet Gynecol. 1983; 147: 277–284.

    PubMed  CAS  Google Scholar 

  94. Spisso KR, Harbert GM, Thiagarajah S. The use of magnesium sulfate as the primary tocolytic agent to prevent premature delivery. Am J Obstet Gynecol. 1982; 142:840–845.

    PubMed  CAS  Google Scholar 

  95. Wilkins IA, Lynch L, Mehalek KE, et al. Efficacy and side effects of magnesium sulfate and ritodrine as tocolytic agents. Am J Obstet Gynecol. 1988;159:685–689.

    PubMed  CAS  Google Scholar 

  96. Miller JM, Keane MW, Horger EO. A comparison of magnesium sulfate and terbutaline for the arrest of premature labor. J Reprod Med. 1982;27:348–351.

    PubMed  Google Scholar 

  97. Beall MH, Edgar BW, Paul RH, et al. A comparison of ritodrine, terbutaline, and magnesium sulfate for the suppression of preterm labor. Am J Obstet Gynecol. 1985; 153:854–859.

    PubMed  CAS  Google Scholar 

  98. Hollander DI, Nagey DA, Pupkin MJ. Magnesium sulfate and ritrodrine hydrochloride: a randomized comparison. Am J Obstet Gynecol. 1987;156:631–637.

    PubMed  CAS  Google Scholar 

  99. Martin RW, Gaddy DK, Martin JN, et al. Tocolysis with oral magnesium. Am J Obstet Gynecol. 1987;156:433–434.

    PubMed  CAS  Google Scholar 

  100. Lipsitz PJ. The clinical and biochemical effects of excess magnesium in the newborn. Pediatrics. 1971;47:501–509.

    PubMed  CAS  Google Scholar 

  101. Green KW, Key TC, Wen R, et al. The effects of maternally administered magnesium sulfate on the neonate. Am J Obstet Gynecol. 1983;146:29–33.

    PubMed  CAS  Google Scholar 

  102. Niebyl JR, Blake DA, White RD, et al. The inhibition of premature labor with indomethacin. Am J Obstet Gynecol. 1980;136:1014–1019.

    PubMed  CAS  Google Scholar 

  103. Dudley DK, Hardie MJ. Fetal and neonatal effects of indomethacin used as a tocolytic agent. Am J Obstet Gynecol. 1985;151:181–184.

    PubMed  CAS  Google Scholar 

  104. Niebyl JR, Witter FR. Neonatal outcome after indomethacin treatment for preterm labor. Am J Obstet Gynecol. 1986;155:747–749.

    PubMed  CAS  Google Scholar 

  105. Moise KJ, Huhta JC, Sharif DS, et al. Indomethacin in the treatment of premature labor. N Engl J Med. 1988;319:327–331.

    PubMed  Google Scholar 

  106. Cabrol D, Landesman R, Muller J, Et al. Treatment of polyhydramnios with prostaglandin synthetase inhibitor (indomethacin). Am J Obstet Gynecol. 1987; 157: 422–426.

    PubMed  CAS  Google Scholar 

  107. Bond A, Druzin M, Edersheim T, et al. Chronic indomethacin administration and oligohydramnios. Presented at meeting of Society of Perinatal Obstetricians; February 1989; New Orleans, La. Abstract 352.

    Google Scholar 

  108. Read MD, Wellby DE. The use of a calcium antagonist (nifedipine) to suppress preterm labour. Br J Obstet Gynecol. 1986;93:933–937

    CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag New York Inc.

About this chapter

Cite this chapter

Treadwell, M.C., Eden, R. (1990). Preterm Labor: Prediction, Prevention, and Treatment. In: Rathi, M. (eds) Current Perinatology. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3380-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-3380-0_4

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7990-7

  • Online ISBN: 978-1-4612-3380-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics